|Day's Range||50.25 - 50.32|
|52 Week Range||31.47 - 50.32|
|PE Ratio (TTM)||-20.13|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alere, Inc. Here are 5 ETFs with the largest exposure to ALR-US. Comparing the performance and risk of Alere, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis Alere, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Alere, Inc. – Quidel Corporation, Bio-Rad Laboratories, Inc. Class A, Abbott Laboratories, Chembio Diagnostics, Inc., Danaher Corporation, Procter & Gamble Company, Hill-Rom Holdings, Inc., OraSure Technologies, Inc., Meridian Bioscience, ... Read more (Read more...)
Waltham diagnostics firm Alere said Wednesday that the U.S. Department of Justice has closed an investigation into the company’s billing practices without filing any charges. Alere (ALR), which has agreed to be acquired by Abbott Laboratories (ABT), said in a first-quarter earnings release that the DOJ informed the company on June 8 that it would not take legal action. The investigation first came to light in July 2016, when the Wall Street Journal reported that Alere had received a criminal subpoena seeking records from its toxicology unit.